Rare disease market access guide launched

Scientist in laboratory

new strategic guide, intended to help manufacturers bring rare disease products to market, has been launched to mark Rare Disease Day (February 28).

In the guide, Terebellum (a subsidiary of AscellaHealth) shares tips on how industry stakeholders can create an effective market access strategy, giving their treatment the best chance of success in a competitive sector.

Features will include why a market access strategy is important and how to develop one effectively, how to build product value, as well as insight into best practices for identifying population size and determining pricing. Readers can also learn which external partners to approach and what specialist knowledge they can acquire to bolster their own teams.

Craig Caceci, Terebellum’s Managing Director, commented: “Bringing any product to market, particularly those used to treat rare and orphan diseases is a challenge enough. But given low patient prevalence, lack of understanding about these diseases and tight budgets, there’s no guarantee your product – however needed it is – will make it to market.

“We understand that companies are up against treatments for a whole range of diseases, all competing for the same budget or funding. However, our new guide explains steps you can take to give yourself the best chance – especially when having a patient for the drug doesn’t necessarily guarantee that your product will enter the market and be paid for.”

Related Articles

Join FREE today and become a member
of Drug Discovery World

Membership includes:

  • Full access to the website including free and gated premium content in news, articles, business, regulatory, cancer research, intelligence and more.
  • Unlimited App access: current and archived digital issues of DDW magazine with search functionality, special in App only content and links to the latest industry news and information.
  • Weekly e-newsletter, a round-up of the most interesting and pertinent industry news and developments.
  • Whitepapers, eBooks and information from trusted third parties.
Join For Free